Performance of IONS Ionis Pharmaceuticals | 20.9% in 12m
Compare IONS with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Ionis Pharmaceuticals with its related Sector/Index XBI
Performance Duell IONS vs XBI
| TimeFrame | IONS | XBI |
|---|---|---|
| 1 Day | -2.60% | 1.86% |
| 1 Week | 0.91% | 7.77% |
| 1 Month | -4.13% | -1.16% |
| 3 Months | -15.6% | 2.28% |
| 6 Months | -11.1% | 25.94% |
| 12 Months | 20.9% | 8.16% |
| YTD | -20.6% | -0.28% |
| Rel. Perf. 1m | 0.02 | |
| Rel. Perf. 3m | -2.06 | |
| Rel. Perf. 6m | -3.41 | |
| Rel. Perf. 12m | 1.05 |
Is Ionis Pharmaceuticals a good stock to buy?
No, based on ValueRay Fundamental Analyses, Ionis Pharmaceuticals (NASDAQ:IONS) is currently (May 2024)
a stock to sell. It has a ValueRay Fundamental Rating of -68.87 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IONS as of May 2024 is 37.52. This means that IONS is currently overvalued and has a potential downside of -10.6% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IONS as of May 2024 is 37.52. This means that IONS is currently overvalued and has a potential downside of -10.6% (Sold with Premium).
Is IONS a buy, sell or hold?
- Strong Buy: 10
- Buy: 6
- Hold: 6
- Sell: 2
- Strong Sell: 0
Values above 0%: IONS is performing better - Values below 0%: IONS is underperforming
Compare IONS with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0.31% | -2.57% | -29.53% | -6.27% |
| US NASDAQ 100 | QQQ | -0.13% | -2.63% | -29.95% | -17.32% |
| US Dow Jones Industrial 30 | DIA | -0.26% | -3.03% | -25.68% | 2.85% |
| German DAX 40 | DBXD | 1.80% | -2.06% | -29.33% | 7.70% |
| UK FTSE 100 | ISFU | -0.75% | -7.34% | -25.43% | 11.40% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -2.60% | -7.76% | -14.27% | 30.63% |
| Hongkong Hang Seng | HSI | -4.85% | -12.19% | -9.86% | 34.72% |
| Japan Nikkei 225 | EXX7 | -1.44% | 0.68% | -24.68% | 0.44% |
| India NIFTY 50 | INDA | 0.13% | -6.16% | -30.49% | -8.26% |
| Brasil Bovespa | EWZ | -1.53% | -4.82% | -15.94% | -3.41% |
IONS Ionis Pharmaceuticals vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.79% | -0.99% | -30.40% | -17.42% |
| Consumer Discretionary | XLY | -0.23% | -2.99% | -22.54% | -2.47% |
| Consumer Staples | XLP | 0.53% | -5.94% | -23.09% | 18.97% |
| Energy | XLE | 4.22% | 0.54% | -19.75% | -0.40% |
| Financial | XLF | 1.57% | -1.49% | -32.15% | -8.29% |
| Health Care | XLV | 0.29% | -1.91% | -22.49% | 13.59% |
| Industrial | XLI | 0.82% | -2.31% | -32.93% | -5.10% |
| Materials | XLB | 0.90% | -0.52% | -25.90% | 4.97% |
| Real Estate | XLRE | -0.63% | -0.46% | -18.35% | 15.89% |
| Technology | XLK | -0.45% | -1.80% | -29.44% | -16.89% |
| Utilities | XLU | -2.44% | -9.21% | -23.61% | 16.89% |
| Aerospace & Defense | XAR | -1.57% | -5.78% | -26.63% | -2.61% |
| Biotech | XBI | -6.86% | -2.97% | -37.00% | 12.69% |
| Homebuilder | XHB | -0.54% | -0.99% | -47.40% | -29.16% |
| Retail | XRT | 0.64% | -1.41% | -30.11% | -2.61% |
Does Ionis Pharmaceuticals outperform its market, is IONS a Sector Leader?
Yes, over the last 12 months Ionis Pharmaceuticals (IONS) made 20.85%, while its related Sector, the SPDR S&P Biotech (XBI) made 8.16%.
Over the last 3 months IONS made -15.64%, while XBI made 2.28%.
Yes, over the last 12 months Ionis Pharmaceuticals (IONS) made 20.85%, while its related Sector, the SPDR S&P Biotech (XBI) made 8.16%.
Over the last 3 months IONS made -15.64%, while XBI made 2.28%.
| Period | IONS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -4.13% | -1.16% | -1.56% |
| 3 Months | -15.64% | 2.28% | 3.75% |
| 12 Months | 20.85% | 8.16% | 27.12% |